STN1010904, Placebo (vehicle), STN1010904
101090401IN
Phase 2 small_molecule active
Quick answer
STN1010904, Placebo (vehicle), STN1010904 for Fuchs Endothelial Corneal Dystrophy (FECD) is a Phase 2 program (small_molecule) at Santen Oy with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Santen Oy
- Indication
- Fuchs Endothelial Corneal Dystrophy (FECD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active